Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

AIMS: We evaluated the effects of patiromer, a potassium (K(+))‐binding polymer, in a pre‐specified analysis of hyperkalaemic patients with heart failure (HF) in the OPAL‐HK trial. METHODS AND RESULTS: Chronic kidney disease (CKD) patients on renin–angiotensin–aldosterone system inhibitors (RAASi) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitt, Bertram, Bakris, George L., Bushinsky, David A., Garza, Dahlia, Mayo, Martha R., Stasiv, Yuri, Christ‐Schmidt, Heidi, Berman, Lance, Weir, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057342/
https://www.ncbi.nlm.nih.gov/pubmed/26459796
http://dx.doi.org/10.1002/ejhf.402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057342/
https://www.ncbi.nlm.nih.gov/pubmed/26459796
http://dx.doi.org/10.1002/ejhf.402

Ejemplares similares